Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Prince

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Neuro-Oncology|March 18, 2020
Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabineDaniel C Moreira, Sujatha Venkataraman, Apurva Subramanian, et al.
Journal of Neurosurgery. Pediatrics|September 27, 2024
Does pre-irradiation gross tumor volume predict the risk of progression after radiation therapy in pediatric patients with adamantinomatous craniopharyngioma?Tamar Brooks, Dexiang Gao, Kathleen Dorris, et al.
Molecular Cancer Research : MCR|February 17, 2025
SIRT2 Regulates the SMARCB1 Loss-Driven Differentiation Block in ATRTIrina Alimova, Dong Wang, John DeSisto, et al.
Pediatric Blood & Cancer|October 10, 2019
Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumorsJessica A Lake, Andrew M Donson, Eric Prince, et al.
Cell Reports|August 14, 2020
Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and EtiologyAustin E Gillen, Kent A Riemondy, Vladimir Amani, et al.
Acta Neuropathologica Communications|August 10, 2024
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progressionJohn R Apps, Jose Mario Gonzalez-Meljem, Romain Guiho, et al.
Acta Neuropathologica Communications|May 15, 2020
Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targetsEric Prince, Ros Whelan, Andrew Donson, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Neuro-Oncology|March 18, 2020
Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabineDaniel C Moreira, Sujatha Venkataraman, Apurva Subramanian, et al.
Journal of Neurosurgery. Pediatrics|September 27, 2024
Does pre-irradiation gross tumor volume predict the risk of progression after radiation therapy in pediatric patients with adamantinomatous craniopharyngioma?Tamar Brooks, Dexiang Gao, Kathleen Dorris, et al.
Molecular Cancer Research : MCR|February 17, 2025
SIRT2 Regulates the SMARCB1 Loss-Driven Differentiation Block in ATRTIrina Alimova, Dong Wang, John DeSisto, et al.
Pediatric Blood & Cancer|October 10, 2019
Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumorsJessica A Lake, Andrew M Donson, Eric Prince, et al.
Cell Reports|August 14, 2020
Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and EtiologyAustin E Gillen, Kent A Riemondy, Vladimir Amani, et al.
Acta Neuropathologica Communications|August 10, 2024
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progressionJohn R Apps, Jose Mario Gonzalez-Meljem, Romain Guiho, et al.
Acta Neuropathologica Communications|May 15, 2020
Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targetsEric Prince, Ros Whelan, Andrew Donson, et al.
Pageof 2